Gildeuretinol for Stargardt disease receives Rare Pediatric Disease, Fast Track Designations
Currently, there are no treatments for the serious, rare pediatric disease.
Food Insecurity and the Dangers of Infant Formula Dilution
Background on whole genome sequencing and review of the GUARDIAN study
Paul Kruszka, MD, MPH, FACMG, chief medical officer of GeneDx, joined us to provide background of whole genome sequencing and its benefits.
Demystifying Infant Formula
COVID-19 among adolescents, teens and type 2 diabetes incidence
A further understanding of the role SARS-CoV-2 plays in T2D incidence can add an important component to benefit and risk considerations to prevent COVID-19.
Prenatally substance-exposed infants and SUID outcomes
Stephanie Anne Deutsch, MD, MS, MSCR, FAAP, joined us to discuss a new study that highlighted SUID among infants who were prenatally substance exposed.
